Skip to main content
Fabian Rodas Ochoa, MD, Internal Medicine, San Antonio, TX

FabianVicenteRodas OchoaMD

Internal Medicine San Antonio, TX

Healthcare Research and Healthcare Policy

Hepatologist/ Director of Liver Transplant services

Dr. Rodas Ochoa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodas Ochoa's full profile

Already have an account?

  • Office

    607 Camden St
    Ste 108
    San Antonio, TX 78215
    Phone+1 210-253-3426
    Fax+1 210-237-4807

Education & Training

  • Carolinas Medical Center
    Carolinas Medical CenterFellowship, Transplant Hepatology, 2016 - 2017
  • St Barnabas Hospital
    St Barnabas HospitalResidency, Internal Medicine, 2009 - 2012
  • University of Cuenca Faculty of Medical Science
    University of Cuenca Faculty of Medical ScienceClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2012 - 2026
  • TX State Medical License
    TX State Medical License 2017 - 2026
  • NC State Medical License
    NC State Medical License 2016 - 2018
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Editor Award Annals of Internal Medicine, 2020

Publications & Presentations

PubMed

Journal Articles

  • Real World experience with Direct Acting Antivirals for Hepatitis C: Baseline resistance, efficacy and need for long-term surveillance,  
    Poordad, F. Rodas, F, Medicine 2019

Abstracts/Posters

  • Liver Transplant Evaluation. A retrospective study from referral through transplant day
    Rodas, F. Russo, M, DDW 2017

Authored Content

  • NAFLD: A pretransplant and post-transplant conundrumMay 2023

Professional Memberships

Industry Relationships

  • Principal Investigador, The Texas Liver InstitutePhase 2 NASH Clinical trials2021 - Present